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Recommendations for Refugee Children
	
1. Background: 
• Lead poisoning remains one of the most common 
and preventable pediatric environmental 
conditions in the United States. 
• Lead is a poison that affects virtually every system 
in the human body. 
• Lead is particularly harmful to the developing brain 
and nervous system of fetuses and young children. 
• The prevalence of elevated blood lead levels 
is much higher among newly resettled refugee 
children in the United States than the 1.6% 
prevalence for U.S. borne children. 
2. Exposure Routes: 
• The most common source of lead exposure for 
children is deteriorated lead paint from older 
housing. 
• The primary route of exposure for children is by 
ingesting house dust or soil contaminated by 
leaded paint. 
• Young children have a higher risk for exposure 
because they have frequent hand-to-mouth activity, 
and they absorb lead more easily than do adults. 
• Children who mouth or eat non-food items, 
especially soil, are at risk for lead poisoning, 
regardless of the age of their housing. This 
occurrence is common among certain refugee 
populations. 
3. Signs and Symptoms: 
• Lead poisoning, for the most part, is 
asymptomatic. The vast majority of cases, 
therefore, go undiagnosed and untreated. 
• Very high lead levels in children can cause severe 
neurologic problems such as coma, convulsion, 
and even death, although such levels are now rare 
in the United States. 
• Lower levels cause adverse effects on the central 
nervous system, kidney, and hematopoietic system. 
• Blood lead levels as low as 10µg/dL, which do 
not cause distinctive symptoms, are associated 
with decreased intelligence and impaired 
neurobehavioral development. 
• Many other effects begin at these low blood lead 
levels, including decreased stature or growth, 
decreased hearing acuity, and decreased ability 
to maintain a steady posture or growth. 
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4. Blood Lead Testing: 
• The American Academy of Pediatrics endorses 
testing children who have emigrated from other 
countries where lead poisoning is prevalent. 
• The Centers for Disease Control and Prevention 
recommends blood lead testing for all refugee 
children who are 6 months to 16 years old upon 
entering the United States. 
• Unlike U.S. children, studies indicate that age 
is not a significant risk factor for elevated BLLs 
among refugee children. 
• Repeat BLL testing of all refugee children who are 
6 months to 6 years of age, 3 to 6 months after 
they are placed in permanent residences, should 
be considered a “medical necessity,” regardless 
of initial test results. 
• Any screening BLL above 10µg/d, not performed 
by venipuncture, must be confirmed with a venous 
sample. 
5. Post-arrival Evaluation and Therapy 
• Upon arriving in the United States, all refugee 
children should have nutritional evaluations 
performed and should be provided with 
appropriate nutritional and vitamin supplements 
as indicated. 
• Pre-existing health burdens such as chronic 
malnutrition increase a refugee child’s risk for 
lead poisoning. 
-	 For example, iron deficiency, prevalent among 
refugee children, increases gastrointestinal 
absorption of lead. 
• At a minimum, the nutritional evaluation should 
contain an evaluation of the children’s iron status, 
including hemoglobin/hematocrit and an evaluation 
of one or more of the following: 
-	 mean corpuscular volume (MCV) combined with 
red cell distribution width (RDW); 
-	 ferritin; 
-	 transferring saturation; or 
-	 reticulocyte hemoglobin content. 
6. Treatment 
• Medical interventions and treatments vary 
depending on the confirmed blood lead level. 
• Detailed information can be found at
www.cdc.gov/nceh/lead/CaseManagement/caseManage_main.htm.
• While chelation therapy is considered a mainstay 
in the medical management of children with BLLs > 
45µg/dL, it should be used with caution. 
• Primary care providers should consult with an expert 
in the management of lead chemotherapy prior to 
using chelation agents. 
7. Long-term Sequelae 
• Neurodevelopmental monitoring should continue 
long after a child’s BLLs have been reduced, as 
many deficits will not manifest themselves until after 
a child starts school. 
• Because development history and testing at the time 
of an elevated BLL usually will not identify lead-
caused problems, a child’s elevated BLL history 
should be part of his permanent record. 
For additional information on lead poisoning 
prevention efforts among refugee children, visit
www.cdc.gov.nceh/lead. 
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